Evaluation of N-acetylcystein on biomarkers of platelet activation and coronary reperfusion in patients undergoing percutaneous coronary intervention.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Acetylcysteine (Primary) ; Acetylcysteine (Primary) ; Aspirin; Clopidogrel; Heparin
- Indications Coronary artery restenosis; Embolism and thrombosis; Myocardial infarction
- Focus Biomarker; Pharmacodynamics
- 21 Dec 2012 New trial record
- 04 Dec 2012 Biomarkers information updated
- 03 Dec 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01741207).